Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma - a podcast by ReachMD

CME credits: 0.25

Valid until: 19-05-2022

Claim your CME credit at https://reachmd.com/programs/cme/creating-personalized-care-relapsedrefractory-follicular-lymphoma/12578/

The epigenetic modulator EZH2 is known to play a crucial role in mediating the lymphomagenesis of follicular lymphoma (FL), and the inhibition of EZH2 in the relapsing/refractory disease setting has shown efficacy. In this activity, Drs. Matasar and Nastoupil discuss the role of EZH2 in the pathobiology of FL, emphasize the need to test for mutations in EZH2 in FL, and explore the potential of targeting EZH2 in different settings of FL treatment.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD